Clinical Trials Logo

Filter by:
NCT ID: NCT01701531 Withdrawn - Anemia Clinical Trials

Red Blood Cell Precursor Formulation to Determine Increased Production

RBCPF
Start date: October 2012
Phase: Phase 2/Phase 3
Study type: Interventional

The objective of this study is to measure the change in hemoglobin levels after the administration of an amino acid based, RBC precursor formulation.

NCT ID: NCT01700972 Withdrawn - Clinical trials for Coronary Artery Disease

Feasibility and Diagnostic Accuracy of Myocardial Perfusion Imaging Using Early Imaging Protocol

Start date: February 2013
Phase: Phase 4
Study type: Interventional

The current protocol for myocardial perfusion imaging (MPI) entails imaging within 30-45 minutes after radiotracer injection, for both rest and stress studies. We hypothesize that early imaging 10 minutes after radiotracer injection provides high image quality and diagnostic accuracy comparable to 30-45 minutes MPI.

NCT ID: NCT01700166 Withdrawn - Clinical trials for Arterial Ischemic Stroke (AIS) in Children

Umbilical Cord Blood in the Treatment of Stroke in Children.

Pedi Stroke
Start date: September 2012
Phase: Phase 1
Study type: Interventional

The specific aims of this study are: 1. To determine if Human Umbilical Cord Blood (hUCB) infusion is safe in children with perinatal arterial ischemic stroke (AIS). 2. To determine if late functional outcome, physiologic response, and anatomic findings are changed following hUCB infusion in children with perinatal AIS.

NCT ID: NCT01700010 Withdrawn - Bladder Cancer Clinical Trials

Trial of Lapatinib and Weekly Paclitaxel for Advanced Urothelial Cancer

Start date: November 2012
Phase: Phase 2
Study type: Interventional

This study will involve subjects who have advanced urothelial cancer who are platinum refractory (platinum based chemotherapies that are not effective in treating the cancer), and who are over-expressing EGFR and/or HER2, or do not over-express EGFR and HER2. Genetic expression is a process that takes inherited information in genes (like DNA sequence), and from that information makes a specific functional product (sometimes called a gene product) such as RNA (ribonucleic acid) or protein. Normal tissue cells have a particular genetic expression, which changes when they turn into cancer. EGFR and HER2 are involved in the process by which normal cells are transformed into cancer cells. The main purpose of the study is to look at the proportion of subjects, who over-express EGFR and/or HER2, who do not progress (cancer gets worse) after 16 weeks of study treatment with daily lapatinib and weekly paclitaxel. The study will also look at the safety and effectiveness of this therapy in all subjects. Another part of this study will look at blood and tissue samples. Blood samples will be collected to see how many cells express EGFR and HER2 before study treatment and at the time the cancer gets worse. Tumor tissue will be analyzed to look at the expression of certain genes in advanced urothelial cancer. Some gene expression tests can reveal how cancer cells are different from normal cells and the results might lead to more accurate diagnosis and treatment.

NCT ID: NCT01697514 Withdrawn - Rhabdomyosarcoma Clinical Trials

A Study of LY2940680 in Pediatric Medulloblastoma or Rhabdomyosarcoma

Start date: July 2013
Phase: Phase 1
Study type: Interventional

The purpose of this study is to find a recommended dose level of LY2940680 that can be safely given to children with medulloblastoma or rhabdomyosarcoma that has returned or doesn't respond to initial treatment. The study will also explore the changes in a cancer marker levels. Finally, the study will help document any antitumor activity.

NCT ID: NCT01695707 Withdrawn - Atopic Dermatitis Clinical Trials

Assessing the Impact of Pioglitazone on Skin Barrier Function in Atopic Dermatitis Patients

Start date: March 2013
Phase: N/A
Study type: Interventional

Many patients with eczema (atopic dermatitis) have an inherent defect in their skin barrier as demonstrated by high water loss. In laboratory conditions, studies have shown that pioglitazone restores the skin barrier function in skin from eczema patients. The purpose of this study is to determine if taking pioglitazone improves the skin barrier function in people with eczema.

NCT ID: NCT01695538 Withdrawn - Clinical trials for Inappropriate Sinus Tachycardia

Yoga and Rate and Duration of Inappropriate Sinus Tachycardia (IST) Episodes

YOGA STAR
Start date: December 2011
Phase: N/A
Study type: Interventional

Inappropriate sinus tachycardia (IST) is an uncommon form of atrial tachycardia. The term "inappropriate" in medicine is commonly defined as a heart rate greater than 100 beats per minute at rest or with minimal physiological challenge. IST is characterized by an increased resting heart rate with an exaggerated response to exercise or stress. Yoga has been used extensively around the world as an alternative medicine approach in treating numerous chronic and debilitating diseases. Studies have been conducted in various countries to determine the benefits of Yoga as therapy for these chronic diseases. Several studies have confirmed that yoga can reduce anxiety and regulate the stress response. Studies in the past have shown that Yoga relieves stress, one of the most common triggers for the arrhythmia and increased heart rate in IST. Based on past studies we hypothesize that patients with IST might benefit by practicing yoga. Yoga may also help in better rate and rhythm control with yoga when employed in combination with usual medical arrangement.

NCT ID: NCT01694589 Withdrawn - Clinical trials for Resectable Pancreatic Cancer

A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer

Start date: November 2012
Phase: Phase 0
Study type: Interventional

We hypothesize that administration of LDE-225 in humans with pancreatic cancer will result in inhibition of paracrine HH signaling in the pancreatic tumor stroma while having no effect on autocrine signaling in the tumor cell compartment. Furthermore we hypothesize that treatment with LDE-225 will result in changes in the tumor stroma (decreased desmoplasia, increased vascularity) that will result in improved tumor blood flow. The purpose of this study is to determine if, where and how LDE-225 works in pancreatic cancer. A cancer cell's growth can depend on the cells and tissue around it. The cells and tissue make chemical signals to influence the cancer's growth. This research study is evaluating LDE-225 designed to interfere with one of the growth signals causing pancreatic cancer growth.

NCT ID: NCT01693913 Withdrawn - Weight Clinical Trials

Cognitive-behavioral Weight Loss Treatment

Start date: October 2012
Phase: N/A
Study type: Interventional

That a treatment using a cognitive-behavioral treatment for exercise and nutrition support will be associated with greater weight loss that a treatment of nutrition and exercise education.

NCT ID: NCT01691352 Withdrawn - Clinical trials for Postoperative Wound Infection

Wick vs. No Wick: Does Method of Closure Affect Rate of Wound Infection?

Start date: January 2012
Phase: N/A
Study type: Interventional

Countless children undergo surgery annually for management of what clinicians consider to be a "dirty wound". One frequently encountered example is the ostomy reversal. During this planned operation, the previously diverted small bowel or colon is reconnected with the distal intestine, restoring continuity. However, this procedure leaves an open wound on the anterior abdominal wall, creating a conundrum for the surgeon and raises the question: how should the wound be managed? In the investigators practice at CHOA, surgeons utilize both a wick and a non-wicked wound dressing. In this prospective randomized trial, we wish to evaluate these two dressings in children receiving an ostomy closure. The investigators hypothesis is that the incidence of wound infection after ostomy reversal is the same regardless of if a wick is placed or not.